Motion sickness susceptibility fluctuates through the menstrual cycle

Aviation Space and Environmental Medicine

Volumn 76, Issue 10, 2005, Pages 970-973

  Golding, John F ^a,b   Kadzere, Priscilla ^a   Gresty, Michael A ^b  

^a UNIVERSITY OF WESTMINSTER   (United Kingdom)

^b CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

Coriolis; Emesis; Gender; Hormones

Indexed keywords

ADULT; ARTICLE; CONTRACEPTION; CORIOLIS PHENOMENON; ENDOCRINE FUNCTION; FEMALE; HEAD MOVEMENT; HEAD TILTING; HUMAN; HUMAN EXPERIMENT; INCIDENCE; MENSTRUAL CYCLE; MOTION SICKNESS; NAUSEA; NORMAL HUMAN; SYMPTOMATOLOGY; VELOCITY; VOMITING;

ADOLESCENT; ADULT; FEMALE; HEAD-DOWN TILT; HUMANS; MENSTRUAL CYCLE; MOTION SICKNESS; MOVEMENT; SEX FACTORS;

EID: 26444504150     PISSN: 00956562     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Clemes SA, Howarth PA. The menstrual cycle and susceptibility to virtual simulation sickness. J Biol Rhythms 2005; 20:71-82.
2. Cheung B, Heskin R, Hofer K, Gagnon M. The menstrual cycle and susceptibility to Coriolis-induced sickness. J Vestib Res 2001; 11:129-36.
3. Dobie T, McBride D, Dobie T Jr, May J. The effects of age and sex on susceptibility to motion sickness. Aviat Space Environ Med 2001; 72:13-20.
4. Golding JF. A simple cross-coupled (Coriolis) motion method for assessing anti-motion sickness drugs. J Psychopharmacol 1996; 10(3, Suppl.):A28.
5. Golding JF. Motion sickness susceptibility questionnaire revised and its relationship to other forms of sickness. Brain Res Bull 1998; 47:507-16.
6. th UK Conference on Human Response to Vibration. Gosport, UK: Institute of Naval Medicine; 2003:89-106.
7. Golding JF, Stott JRR. Comparison of the effects of a selective muscarinic receptor antagonist and hyoscine (scopolamine) on motion sickness, skin conductance and heart rate. Br J Clin Pharmacol 1997; 43:633-7.
8. Golding JF, Bles W, Bos JE, et al. Motion sickness and tilts of the inertial force environment: active suspension systems versus active passengers. Aviat Space Environ Med 2003; 74:220-7.
9. Grunfeld E, Price C, Goadsby P, Gresty M. Migraine motion sickness and menstruation in mariners. Lancet 1998; 351:1106.
10. Javid FA, Naylor RJ. Variables of movement amplitude and frequency in the development of motion sickness in Suncus murinus. Pharmacol Biochem Behav 1999; 64:115-22.
11. Kennedy RS, Lanham DS, Massey CJ, Drexler JM. Gender differences in simulator sickness incidence: implications for military virtual reality systems. SAFE J 1995; 25:69-76.
12. Lawther A, Griffin MJ. A survey of the occurrence of motion sickness amongst passengers at sea. Aviat Space Environ Med 1988; 59:399-406.
13. Money KE, Cheung BS. Another function of the inner ear: facilitation of the emetic response to poisons. Aviat Space Environ Med 1983; 54:208-11.
14. Morrow GR. The effect of a susceptibility to motion sickness on the side effects of cancer chemotherapy. Cancer 1985; 55:2766-70.
15. Treisman M. Motion sickness: an evolutionary hypothesis. Science 1977; 197:493-5.
16. Yen-Pik-Sang F, Billar JP, Golding JF, Gresty MA. Behavioral methods of alleviating motion sickness: effectiveness of controlled breathing and music audiotape. J Travel Med 2003; 10:108-12.